Literature DB >> 35325556

Analyzing Opposing Interactions Between Sphingosine 1-Phosphate Lyase and Influenza A Virus.

Jennifer J Wolf1, Julie D Saba2, Bumsuk Hahm1.   

Abstract

Sphingosine 1-phosphate lyase (SPL) is a critical component of sphingosine 1-phosphate (S1P) metabolism. SPL has been associated with several crucial cellular functions due to its role in S1P metabolism, but its role in viral infections is poorly understood. Studies show that SPL has an antiviral function against influenza A virus (IAV) by interacting with IKKɛ, promoting the type I interferon (IFN) innate immune response to IAV infection. However, a more recent study has revealed that IAV NS1 protein hampers this by triggering ubiquitination and subsequent degradation of SPL, which reduces the type I IFN innate immune response. In this study, we describe SPL, the type I IFN response, and known interactions between SPL and IAV.

Entities:  

Keywords:  influenza A virus; sphingosine-1-phosphate lyase; type I interferon; viral immune evasion; virus–host interactions

Mesh:

Substances:

Year:  2022        PMID: 35325556      PMCID: PMC9063141          DOI: 10.1089/dna.2022.0071

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.550


  46 in total

1.  PDGF signaling specificity is mediated through multiple immediate early genes.

Authors:  Jennifer Schmahl; Christopher S Raymond; Philippe Soriano
Journal:  Nat Genet       Date:  2006-12-03       Impact factor: 38.330

2.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.

Authors:  Ji-Young Min; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

Review 3.  Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine.

Authors:  Florian Krammer; Adolfo García-Sastre; Peter Palese
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

Review 4.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I.

Authors:  Alexander S Jureka; Alex B Kleinpeter; Jennifer L Tipper; Kevin S Harrod; Chad M Petit
Journal:  J Biol Chem       Date:  2019-12-16       Impact factor: 5.157

6.  Sply regulation of sphingolipid signaling molecules is essential for Drosophila development.

Authors:  Deron R Herr; Henrik Fyrst; Van Phan; Karie Heinecke; Rana Georges; Greg L Harris; Julie D Saba
Journal:  Development       Date:  2003-06       Impact factor: 6.868

Review 7.  Sphingosine-1-phosphate: an enigmatic signalling lipid.

Authors:  Sarah Spiegel; Sheldon Milstien
Journal:  Nat Rev Mol Cell Biol       Date:  2003-05       Impact factor: 94.444

8.  Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.

Authors:  Jennifer J Wolf; Chuan Xia; Caleb J Studstill; Hanh Ngo; Steven L Brody; Paul E Anderson; Bumsuk Hahm
Journal:  Virology       Date:  2021-03-13       Impact factor: 3.513

9.  Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.

Authors:  Lenee Blanton; Vivien G Dugan; Anwar Isa Abd Elal; Noreen Alabi; John Barnes; Lynnette Brammer; Alicia P Budd; Erin Burns; Charisse N Cummings; Shikha Garg; Rebecca Garten; Larisa Gubareva; Krista Kniss; Natalie Kramer; Alissa O'Halloran; Carrie Reed; Melissa Rolfes; Wendy Sessions; Calli Taylor; Xiyan Xu; Alicia M Fry; David E Wentworth; Jacqueline Katz; Daniel Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-02-15       Impact factor: 17.586

10.  Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.

Authors:  Giovanni Marfia; Stefania Navone; Laura Guarnaccia; Rolando Campanella; Michele Mondoni; Marco Locatelli; Alessandra Barassi; Laura Fontana; Fabrizio Palumbo; Emanuele Garzia; Giuseppe Ciniglio Appiani; Davide Chiumello; Monica Miozzo; Stefano Centanni; Laura Riboni
Journal:  EMBO Mol Med       Date:  2020-12-09       Impact factor: 14.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.